EUROPEAN JOURNAL OF PHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2263100, encodeId=c120226310050, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 22:45:21 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2263034, encodeId=3242226303467, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 08:44:02 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248320, encodeId=b2d2224832068, content=UR2个月还没返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Thu Jan 16 12:17:17 CST 2025, time=2025-01-16, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2248666, encodeId=8ee5224866610, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：一直没有审稿人审稿，有点焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Sat Jan 18 17:58:20 CST 2025, time=2025-01-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2247953, encodeId=f52d224e95319, content=2025.1.1 投稿 2025.1.6 with editor 2025.1.13 reject 可能是方向不太符合，transform过来的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Mon Jan 13 22:18:54 CST 2025, time=2025-01-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京)]

2025-05-01 sunyong_97 来自江苏省

前往app查看评论内容

1 0

[GetPortalCommentsPageByObjectIdResponse(id=2263100, encodeId=c120226310050, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 22:45:21 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2263034, encodeId=3242226303467, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 08:44:02 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248320, encodeId=b2d2224832068, content=UR2个月还没返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Thu Jan 16 12:17:17 CST 2025, time=2025-01-16, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2248666, encodeId=8ee5224866610, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：一直没有审稿人审稿，有点焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Sat Jan 18 17:58:20 CST 2025, time=2025-01-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2247953, encodeId=f52d224e95319, content=2025.1.1 投稿 2025.1.6 with editor 2025.1.13 reject 可能是方向不太符合，transform过来的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Mon Jan 13 22:18:54 CST 2025, time=2025-01-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京)]

2025-05-01 sunyong_97 来自江苏省

前往app查看评论内容

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2263100, encodeId=c120226310050, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 22:45:21 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2263034, encodeId=3242226303467, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 08:44:02 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248320, encodeId=b2d2224832068, content=UR2个月还没返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Thu Jan 16 12:17:17 CST 2025, time=2025-01-16, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2248666, encodeId=8ee5224866610, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：一直没有审稿人审稿，有点焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Sat Jan 18 17:58:20 CST 2025, time=2025-01-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2247953, encodeId=f52d224e95319, content=2025.1.1 投稿 2025.1.6 with editor 2025.1.13 reject 可能是方向不太符合，transform过来的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Mon Jan 13 22:18:54 CST 2025, time=2025-01-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京)]

2025-04-24 ms4000000082043336 来自河南省

审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了

2 0

[GetPortalCommentsPageByObjectIdResponse(id=2263100, encodeId=c120226310050, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 22:45:21 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2263034, encodeId=3242226303467, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 08:44:02 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248320, encodeId=b2d2224832068, content=UR2个月还没返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Thu Jan 16 12:17:17 CST 2025, time=2025-01-16, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2248666, encodeId=8ee5224866610, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：一直没有审稿人审稿，有点焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Sat Jan 18 17:58:20 CST 2025, time=2025-01-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2247953, encodeId=f52d224e95319, content=2025.1.1 投稿 2025.1.6 with editor 2025.1.13 reject 可能是方向不太符合，transform过来的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Mon Jan 13 22:18:54 CST 2025, time=2025-01-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京)]

2025-03-04 Tilen 来自北京

审稿速度:2.0
偏重的研究方向：心血管病
经验分享：二审后dip2周了，接心软编辑，hope

15 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2263100, encodeId=c120226310050, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 22:45:21 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2263034, encodeId=3242226303467, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 08:44:02 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248320, encodeId=b2d2224832068, content=UR2个月还没返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Thu Jan 16 12:17:17 CST 2025, time=2025-01-16, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2248666, encodeId=8ee5224866610, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：一直没有审稿人审稿，有点焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Sat Jan 18 17:58:20 CST 2025, time=2025-01-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2247953, encodeId=f52d224e95319, content=2025.1.1 投稿 2025.1.6 with editor 2025.1.13 reject 可能是方向不太符合，transform过来的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Mon Jan 13 22:18:54 CST 2025, time=2025-01-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京)]

2025-01-06 ms9000000976333684 来自浙江省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：药理学;炎症
经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了

24 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2263100, encodeId=c120226310050, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 22:45:21 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2263034, encodeId=3242226303467, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 08:44:02 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248320, encodeId=b2d2224832068, content=UR2个月还没返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Thu Jan 16 12:17:17 CST 2025, time=2025-01-16, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2248666, encodeId=8ee5224866610, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：一直没有审稿人审稿，有点焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Sat Jan 18 17:58:20 CST 2025, time=2025-01-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2247953, encodeId=f52d224e95319, content=2025.1.1 投稿 2025.1.6 with editor 2025.1.13 reject 可能是方向不太符合，transform过来的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Mon Jan 13 22:18:54 CST 2025, time=2025-01-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京)]

2025-01-16 ms8000001635701835 来自山西省

UR2个月还没返回

18 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2263100, encodeId=c120226310050, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 22:45:21 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2263034, encodeId=3242226303467, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 08:44:02 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248320, encodeId=b2d2224832068, content=UR2个月还没返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Thu Jan 16 12:17:17 CST 2025, time=2025-01-16, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2248666, encodeId=8ee5224866610, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：一直没有审稿人审稿，有点焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Sat Jan 18 17:58:20 CST 2025, time=2025-01-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2247953, encodeId=f52d224e95319, content=2025.1.1 投稿 2025.1.6 with editor 2025.1.13 reject 可能是方向不太符合，transform过来的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Mon Jan 13 22:18:54 CST 2025, time=2025-01-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京)]

2025-01-18 ms6000001668743180 来自广西

偏重的研究方向：药理学;肿瘤;药理
经验分享：一直没有审稿人审稿，有点焦急

19 0

[GetPortalCommentsPageByObjectIdResponse(id=2263100, encodeId=c120226310050, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 22:45:21 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2263034, encodeId=3242226303467, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 08:44:02 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248320, encodeId=b2d2224832068, content=UR2个月还没返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Thu Jan 16 12:17:17 CST 2025, time=2025-01-16, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2248666, encodeId=8ee5224866610, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：一直没有审稿人审稿，有点焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Sat Jan 18 17:58:20 CST 2025, time=2025-01-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2247953, encodeId=f52d224e95319, content=2025.1.1 投稿 2025.1.6 with editor 2025.1.13 reject 可能是方向不太符合，transform过来的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Mon Jan 13 22:18:54 CST 2025, time=2025-01-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京)]

2025-01-13 ms6000000673439938 来自甘肃省

2025.1.1 投稿
2025.1.6 with editor
2025.1.13 reject
可能是方向不太符合，transform过来的

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2263100, encodeId=c120226310050, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 22:45:21 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2263034, encodeId=3242226303467, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 08:44:02 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248320, encodeId=b2d2224832068, content=UR2个月还没返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Thu Jan 16 12:17:17 CST 2025, time=2025-01-16, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2248666, encodeId=8ee5224866610, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：一直没有审稿人审稿，有点焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Sat Jan 18 17:58:20 CST 2025, time=2025-01-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2247953, encodeId=f52d224e95319, content=2025.1.1 投稿 2025.1.6 with editor 2025.1.13 reject 可能是方向不太符合，transform过来的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Mon Jan 13 22:18:54 CST 2025, time=2025-01-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京)]

2024-08-23 研究牲小F 来自甘肃省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肾脏;药理学
经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！

66 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2263100, encodeId=c120226310050, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 22:45:21 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2263034, encodeId=3242226303467, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Thu May 01 08:44:02 CST 2025, time=2025-05-01, status=0, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248320, encodeId=b2d2224832068, content=UR2个月还没返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a339482827, createdName=ms8000001635701835, createdTime=Thu Jan 16 12:17:17 CST 2025, time=2025-01-16, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2248666, encodeId=8ee5224866610, content=偏重的研究方向：药理学;肿瘤;药理 经验分享：一直没有审稿人审稿，有点焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Sat Jan 18 17:58:20 CST 2025, time=2025-01-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2247953, encodeId=f52d224e95319, content=2025.1.1 投稿 2025.1.6 with editor 2025.1.13 reject 可能是方向不太符合，transform过来的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64406517662, createdName=ms6000000673439938, createdTime=Mon Jan 13 22:18:54 CST 2025, time=2025-01-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京)]

2024-10-30 14778916m81暂无昵称来自北京

9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗

35 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务